Back to results
US 12,662,456 B2Granted
Dextrorphan prodrugs and processes for making and using them
AssigneeZevra Therapeutics, Inc.
InventorsTravis Mickle, Sven Guenther, Sanjib Bera
Life of this patent
Estimating the term…
Abstract
The presently described technology provides compositions of one or more of oxoacids, polyethylene glycols, and vitamin compounds chemically conjugated to dextrorphan, (+)-17-methylmorphinan-3-ol), to form novel prodrugs and compositions of levorphanol.
Claims16
A compound having the following general formula:
- where L1 is
- and L2 is absent, or
- Y1 and Y2 are independently either absent, or [A-X—Z]n
- where A and Z are independently selected for Y1 and Y2, and are, independent of each other, either absent or selected from —O—, —S—, or —(CR1R2)k—,
- and where X is —(CR1R2)—;
- J is [M-W]p
- where M is —(CR3R4)q—;
- and W is absent, or —O— or —S—
- R1 and R2 are each independently selected for Y1 and Y2, and are, independent of each other, selected from H, alkyl, aryl, alkylaryl, alkoxy, haloalkyl, or haloaryl
- R3 and R4 are each independently selected from H, alkyl, aryl, alkylaryl, alkoxy, haloalkyl, or haloaryl
- for each Y1 and Y2, n is independently an integer of 1-4
- for each repeating unit of [A-X—Z]n, when —(CR1R2)k— is present, k is independently an integer of 1-4,
- p and q are independently selected from 1-4
- G1m and G2m are independently absent, or selected independently of each other and, when present, each repeating subunit is independently selected from H, oxoacid, polyethylene glycol having from 2 to 5 ethylene oxide units, or a vitamin compound;
- where m is selected independently for G1 and G2, and is an integer of 1-4, except that m is 1 when G1 or G2 is a hydrogen atom;
- or a pharmaceutically acceptable salt thereof.
13 more elements
Dependencies are inferred from the claim text.